Agile Lifescience Technologies India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 17-06-2024
- Paid Up Capital ₹ 1.80 M
as on 17-06-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.63 Cr
as on 17-06-2024
- Satisfied Charges ₹ 0.50 M
as on 17-06-2024
- Revenue 97.55%
(FY 2022)
- Profit 116.09%
(FY 2022)
- Ebitda 3.96%
(FY 2022)
- Net Worth 21.31%
(FY 2022)
- Total Assets 10.51%
(FY 2022)
About Agile Lifescience Technologies India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.80 M.
The company currently has active open charges totaling ₹2.63 Cr. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Srikanth Seshadri and Srinivasan Krishna serve as directors at the Company.
- CIN/LLPIN
U33125MH2006PTC162451
- Company No.
162451
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Agile Lifescience Technologies India Private Limited offer?
Agile Lifescience Technologies India Private Limited offers a wide range of products and services, including Volumetric Pipette, Micropipette, Single Channel Pipette, Plastic & Glass Labware, Pipette, Measuring Equipments & Instruments, Digital Counters, Electronic Pipette, Pumps, Pumping Machines & Spares, Vane Pump.
Who are the key members and board of directors at Agile Lifescience Technologies India?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srikanth Seshadri | Director | 08-Jun-2006 | Current |
Srinivasan Krishna | Director | 20-Nov-2006 | Current |
Financial Performance of Agile Lifescience Technologies India.
Agile Lifescience Technologies India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 97.55% increase. The company also saw a substantial improvement in profitability, with a 116.09% increase in profit. The company's net worth Soared by an impressive increase of 21.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Agile Lifescience Technologies India?
In 2022, Agile Lifescience Technologies India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 17 Dec 2015 | ₹8.02 M | Open |
Others Creation Date: 04 Nov 2008 | ₹3.50 M | Open |
The Saraswat Co-Operative Bank Limited Creation Date: 07 Jun 2008 | ₹0.50 M | Open |
How Many Employees Work at Agile Lifescience Technologies India?
Unlock and access historical data on people associated with Agile Lifescience Technologies India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agile Lifescience Technologies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agile Lifescience Technologies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.